Seegene Launches Innovative mpox Detection Assays for Research
Seegene Unveils Advanced mpox Detection Solutions
In a remarkable advancement in public health research, Seegene Inc. has announced the launch of its new Novaplex™ MPXV/OPXV plus Assay. This cutting-edge research-use-only (RUO) assay is engineered to specifically target and detect the mpox virus, particularly Clade I, known for its higher transmission rates and associated mortality risks compared to Clade II.
New Assay Targets for Enhanced Accuracy
Unique Features of the Novaplex™ Assay
The Novaplex™ MPXV/OPXV plus Assay is designed to identify non-variola Orthopoxvirus (OPXV) alongside the mpox virus (MPVX). Notably, it provides precise confirmation of MPXV Clade I infections, offering vital assistance to healthcare professionals in their research endeavors, especially during this current challenge of mpox's spread.
Alignment with International Health Standards
In accordance with the World Health Organization's (WHO) target product profiles, Seegene's latest assay promises accurate viral strain detection. By adhering to these guidelines, the assay aids in ensuring that healthcare professionals can identify emerging mpox cases accurately, thereby supporting global health efforts effectively.
Global Health Response Initiatives
Seegene has demonstrated a proactive approach in addressing the recent global public health emergency related to mpox. The WHO has classified the mpox outbreak as a Public Health Emergency of International Concern (PHEIC), prompting Seegene to develop two new assays tailored for urgent global needs.
The Novaplex™ MPXV/OPXV Assay (RUO) is not alone in its capacity; there’s also the Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO), which simultaneously detects four viruses, including mpox and several strains of the herpes virus. Both assays align with the WHO's criteria, ensuring that researchers have the tools necessary to address the virus's spread comprehensively.
Commitment to Combatting mpox Spread
Daniel Shin, Seegene’s Executive Vice-President and Chief Global Sales and Marketing Officer, expressed the company’s dedication to combatting the mpox virus. "As we witness the persistent spread of mpox, we have intensified our efforts to develop RUO assays that fulfill the urgent research demands of affected nations,” he said.
The Broader Impact of mpox
To provide context on the ongoing crisis, the Africa Centres for Disease Control and Prevention reports alarming numbers from January to September 2024, with over 24,851 suspected and 5,549 confirmed cases, which highlights the urgent need for effective detection tools.
Notably, mpox is expanding beyond its traditional regions, with cases emerging in various countries, including Sweden, Pakistan, and Thailand. This underscores the global nature of the threat posed by mpox, making advanced detection solutions more crucial than ever.
About Seegene
Seegene brings over 23 years of expertise in research, development, and manufacturing focused on multiplex PCR technologies. Their capabilities gained widespread recognition during the pandemic, enabling them to deliver over 340 million COVID-19 tests to more than 100 nations. By allowing simultaneous testing of multiple pathogens, Seegene’s technology is vital for answering global health challenges.
Frequently Asked Questions
What is the Novaplex™ MPXV/OPXV plus Assay?
The Novaplex™ MPXV/OPXV plus Assay is a new PCR assay designed to detect mpox Clade I and other Orthopoxviruses to support research efforts globally.
Why is mpox Clade I concerning?
MPXV Clade I poses higher transmission and mortality risks compared to other variants, making accurate detection critically important.
How does Seegene's assay help healthcare professionals?
By adhering to WHO standards and accurately diagnosing infections, the assay provides healthcare professionals necessary insights for managing outbreaks.
What other products have been developed by Seegene?
In addition to the new mpox assays, Seegene also offers assays that test for herpes simplex viruses, significantly broadening the scope of their research utility.
What is Seegene's experience in diagnostics?
With decades of experience, Seegene is recognized for its advanced PCR technology and for delivering millions of tests to tackle global health crises effectively.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Innovative Leadership: Elevate's Brian Strom Recognized
- Growth Forecast of the InGaAs Camera Market Through 2033
- What Investors Are Focusing On for SoFi Technologies
- 92% of Americans Back Efforts for Healthcare Price Transparency
- Recent Options Market Activity Signals Change for AXL Stock
- Highmark Expands Coverage for AppliedVR's Innovative Therapy
- NIL Platform Nilly Partners With Harlan Capital to Help Athletes
- Transform Your Life with the Inspiring Coffee Table Book
- MNA Nurses Stand United at Marlborough Hospital for Change
- Legal Action for Investors of CVS Health Corporation Securities
Recent Articles
- Baileys and Phillip Lim Unveil Fashion-Forward Market Tote
- Gaby Natale Becomes Susan G. Komen Ambassador for Advocacy
- Top MBA Programs for Aspiring Business Leaders in 2025
- Emergency Preparedness: Hill's Pet Nutrition Enriches Lives
- Nexion Travel Group Survey Reveals Insights on Travel Careers
- Golden Goose Experiences Significant Growth in Profitability
- Stock Market Insights: Denmark's OMX Copenhagen 20 Gains Momentum
- Whales Accumulate Bitcoin Amid Market Fluctuations and Speculations
- Bybit Showcases Web3 Innovations at Token 2049 Singapore Event
- Exploring the Rapid Growth of Automotive Robotics Industry
- Veterinary Hematology Analyzers Set for Major Growth by 2034
- Newmark Leads $5 Billion Partnership for AI Data Centers
- Celebrating 25 Years of Schneider Electric Foundation's Impact
- Understanding Recent Changes in Oshkosh Short Interest
- Analyzing Qualcomm's Short Interest Trends and Impact
- Understanding Light & Wonder's Increasing Short Interest Trends
- JPMorgan Upgrades Ratings for Key Steel Companies Amid Rebound
- Unlocking Creativity: A Dive into AI Copywriting Masterclass
- Pavlov Media Joins Forces with CDG to Elevate Service Offerings
- Nium Expands Leadership Team with Strategic CFO and CCO Appointments
- Strategic Partnership Aims to Revolutionize Data Centers in U.S.
- Recognition of Operational Psychologist for Staffing Excellence
- Stable Inflation Outlook Highlights Consumer Sentiment Trends
- French Economy Faces Challenges Post-Olympics, Says INSEE Forecast
- Key Insights from Recent Stock Movements in Israel's Market
- Oslo OBX Index Sees Gains as Key Sectors Shine Bright
- Hermès Stock: Insights on Morgan Stanley's Revised Forecasts
- Moroccan Stock Market Sees Growth with All Shares Rising 0.51%
- The Case for Embracing the Equal-Weighted S&P 500 Index
- Why Jefferies Predicts a Strong Q3 for McDonald's Performance
- Citigroup's CFO Predicts Significant Uptick in Banking Fees
- Pete Rose Unveils Unique Legal Tender Collectibles
- Chopped Leaf Unveils the Irresistible Goddess Bowl Again
- Projected Growth of the Global Protective Packaging Market
- Projected Growth of Splash Shield Market to USD 407.67 Million
- Analyzing Super Micro Computer's Challenges and Opportunities
- Market Recovery: Key Factors Behind Recent Stock Trends
- The MRI Market's Future: Growth and Innovations Ahead
- Exploring the Growth of Mobile Virtual Network Operators
- Exploring the Growth of the Global Vehicle Subscription Market
- Stand Up Paddleboard Market Set for Remarkable Growth Ahead
- Exploring the Surge of Health Coaching: A $28 Billion Market
- Exploring the Future of RNA Therapeutics: Market Insights
- Global Growth of Nuclear Waste Management Market by 2031
- UTime Limited Implements Major Reverse Share Split Strategy
- Oil Price Dynamics Ahead of Possible Gulf Coast Storm
- Snaige AB Reports Strong Interim Results for 2024
- UTime Limited Implements 1-for-25 Share Consolidation Plan
- Norsk Hydro Expands Ownership in Vianode through a Strategic Move
- Pelorus Management Group Responds to False Claims by Arena